Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Degraded TPO agonist antibody

Degraded TPO agonist antibody

US Patent 8034903 · Granted Oct 11, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for controlling blood pharmacokinetics of antibodies2025
Method of modifying isoelectric point of antibody via amino acid substitution in2024
Method of modifying isoelectric point of antibody via amino acid substitution in2024
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 an2023
GPC3-targeting drug which is administered to patient responsive to GPC3-targetin2023
AntiPlexin A1 agonist antibody2023
GPC3-targeting therapeutic agent which is administered to patient for whom the G2022
Method of modifying isoelectric point of antibody via amino acid substitution in2022
Methods for producing polypeptides by regulating polypeptide association2021
Methods for controlling blood pharmacokinetics of antibodies2021
Methods of modifying antibodies for purification of bispecific antibodies2021
GPC3-targeting drug which is administered to patient responsive to GPC3-targetin2020